Join the Conversation! | https://trialsitenews.com/ Mumbai Move for Ivermectin Prophylaxis While Uttar Pradesh Smashes COVID-19: With ivermectin now on the national Indian COVID-19 list of recommended treatments for COVID-19, a few states have gone to the next level and included the low-cost, generic drug approved throughout the world as a parasite fighter as a prophylactic targeting SARS-CoV-2, the virus behind COVID-19. Three Indian states, including Goa, Karnataka and Uttarakhand, have authorized ivermectin as a prophylaxis along with vitamin D during the pandemic. Article Link | https://trialsitenews.com/mumbai-move-for-ivermectin-prophylaxis-while-uttar-pradesh-smashes-covid-19-but-drugs-use-suppressed-in-media/ Indian Bar Association Serves Legal Notice Upon Dr. Soumya Swaminathan, the Chief Scientist, WHO: Dr. Soumya Swaminathan, the Chief Scientist at the World Health Organisation (WHO), was apparently served a legal notice by Indian Bar Association (IBA) on May 25, 2021, for her alleged act of spreading disinformation and thus misleading the people of India, in order to fulfill her own agenda, so the plaintiff’s action declares. Article | https://trialsitenews.com/indian-bar-association-serves-legal-notice-upon-dr-soumya-swaminathan-the-chief-scientist-who/ ... https://www.youtube.com/watch?v=Zu_t3jgahqs

Join us as we go over our top stories from the week: Fred Hutchinson Cancer Research Center Collaborates with Alkermes plc to Conduct Clinical Trial for Novel Immuno-Oncology Drug Candidate. UC San Diego Moores Cancer Center Immunotherapy Clinic Reveals the Future is Now. Pancreatic Cancer Drug Developed by Stony Brook University Moves into Phase III Clinical Trials. Could Autism be an Autoimmune Disorder? Investigators at Beth Israel Deaconess Medical Center (BIDMC) Think Possibly. University of Minnesota Opens First-Ever U.S. Clinical Trial of Engineered iPSC-derived Cell Therapy for Blood Cancer. Odonate Therapeutics Announces Patient Enrollment Completion for CONTESSA, a Phase 3 Study of Tesetaxel in Patients with Metastatic Breast Cancer. Asia-focused Non-Invasive Colon Detection Technology to be Commercialized by Alibaba-backed Digital Health Venture. Privately-Held Segal Clinical Supports Usona Institute’s PSIL201 Clinical Trial Testing the Use of Psilocybin for Major Depression. ASDS Awards Eight Clinical and Cosmetic Research Grants. $14.6 Million in Awards Granted to 43 Multiple Sclerosis Projects by National MS Society. Dynamic University of Rio Grande do Norte Investigator Headed to University of Auckland to Discuss Research into Ayahuasca for Antidepressant Properties. Looking for Earliest Stages of Cancer Leads to Radically Innovative Research by International Alliance. Health Systems Increasingly Step into Clinical Trials Participation: The PIER Consortium™ Example. i-Mab Biopharma Expands its Study of MOR202 for Multiple Myeloma Patients in Dozens of Sites in China. La Jolla Institute of Immunology Adopts Seqster Platform to Support Study Pursuing Personalized Asthma Treatments as part of $6.9M NHLBI Study. .University of Colorado Anschutz Medical Campus Awarded $4M as Part of NIH Commercialization Hub Program called REACH. Timestamps Cancer 00:31 Autism 03:50 Opioid Use 04:20 Clinical Trial News 05:29 Neurodegenerative 07:21 Asthma 07:55 ... https://www.youtube.com/watch?v=_aUh242t290

With mass media synchronization, that is recent ivermectin-based articles from both the New York Times and CNN covering negative news, the U.S. Food and Drug Administration (FDA), the Gold Standard global food and drug regulatory body, has issued a cautionary statement targeting ivermectin. The crux of the agency’s concern includes 1) Ivermectin is an off label treatment; 2) taking large doses of the drug can be harmful; 3) ivermectin should be used for “legitimate” source (e.g. anti-parasitic indication); and 4) animal medications should never be taken by humans. The basis for the agency’s warnings are “multiple reports” of individuals that have received either medical support for taking the drug or hospitalization after self-medication with the type needed for animals. No such data backing those reports is included, however—no warning letters, no examples from county or state health agencies or for that matter tangible reports from hospitals. ... https://www.youtube.com/watch?v=pDNudfR9Iuk

Join The Conversation! | https://trialsitenews.com/ Gabriel Nathan is Editor of OC87 Recovery Diaries, suicide prevention advocate, a writer, actor and star of the documentary, A Beautiful Day Tomorrow. A Beautiful Day Tomorrow: Taking Suicide Awareness on the Road – A charming, sweet, human movie about a man and a car, devoted to spreading suicide awareness and prevention everywhere they go. Link | https://abeautifuldaytomorrow.com/ ... https://www.youtube.com/watch?v=gj5QnbeN_R8